These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

638 related articles for article (PubMed ID: 21860817)

  • 21. Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome.
    Xiao L; Liu Q; Luo M; Xiong L
    Front Cell Infect Microbiol; 2021; 11():729346. PubMed ID: 34631603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dietary modulation of gut microbiota for the relief of irritable bowel syndrome.
    Kim MY; Choi SW
    Nutr Res Pract; 2021 Aug; 15(4):411-430. PubMed ID: 34349876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurotransmitter and Intestinal Interactions: Focus on the Microbiota-Gut-Brain Axis in Irritable Bowel Syndrome.
    Chen M; Ruan G; Chen L; Ying S; Li G; Xu F; Xiao Z; Tian Y; Lv L; Ping Y; Cheng Y; Wei Y
    Front Endocrinol (Lausanne); 2022; 13():817100. PubMed ID: 35250873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of Acupuncture on the Gut-Brain-Microbiota Axis in Irritable Bowel Syndrome.
    Yaklai K; Pattanakuhar S; Chattipakorn N; Chattipakorn SC
    Am J Chin Med; 2021; 49(2):285-314. PubMed ID: 33622207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Irritable bowel syndrome: a gut microbiota-related disorder?
    Bhattarai Y; Muniz Pedrogo DA; Kashyap PC
    Am J Physiol Gastrointest Liver Physiol; 2017 Jan; 312(1):G52-G62. PubMed ID: 27881403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome.
    König J; Brummer RJ
    Benef Microbes; 2014 Sep; 5(3):247-61. PubMed ID: 24583610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular signalling during cross talk between gut brain axis regulation and progression of irritable bowel syndrome: A comprehensive review.
    Singh SV; Ganguly R; Jaiswal K; Yadav AK; Kumar R; Pandey AK
    World J Clin Cases; 2023 Jul; 11(19):4458-4476. PubMed ID: 37469740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome.
    Kane JS; Ford AC
    Expert Rev Gastroenterol Hepatol; 2016; 10(4):431-42. PubMed ID: 26753693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Irritable Bowel Syndrome, Depression, and Neurodegeneration: A Bidirectional Communication from Gut to Brain.
    Aziz MNM; Kumar J; Muhammad Nawawi KN; Raja Ali RA; Mokhtar NM
    Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gut microbiota signatures and modulation in irritable bowel syndrome.
    Marasco G; Cremon C; Barbaro MR; Stanghellini V; Barbara G
    Microbiome Res Rep; 2022; 1(2):11. PubMed ID: 38045643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
    Barbara G; Zecchi L; Barbaro R; Cremon C; Bellacosa L; Marcellini M; De Giorgio R; Corinaldesi R; Stanghellini V
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gut microbiota and intestinal immunity-A crosstalk in irritable bowel syndrome.
    Chen Y; Feng S; Li Y; Zhang C; Chao G; Zhang S
    Immunology; 2024 May; 172(1):1-20. PubMed ID: 38174581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Probiotics and irritable bowel syndrome.
    Korpela R; Niittynen L
    Microb Ecol Health Dis; 2012; 23():. PubMed ID: 23990830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The putative role of the intestinal microbiota in the irritable bowel syndrome.
    Collins SM; Denou E; Verdu EF; Bercik P
    Dig Liver Dis; 2009 Dec; 41(12):850-3. PubMed ID: 19740713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of water extracts from Cynanchum thesioides (Freyn) K. Schum. on visceral hypersensitivity and gut microbiota profile in maternally separated rats.
    Lingpeng P; Jingzhu S; Wei L; Enqi W; Yaqin L
    J Ethnopharmacol; 2021 Jan; 264():113352. PubMed ID: 32891821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Probiotics, Prebiotics, and Synbiotics: Implications and Beneficial Effects against Irritable Bowel Syndrome.
    Simon E; Călinoiu LF; Mitrea L; Vodnar DC
    Nutrients; 2021 Jun; 13(6):. PubMed ID: 34203002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Research Progress in Fecal Microbiota Transplantation as Treatment for Irritable Bowel Syndrome.
    Wang Y; Zheng F; Liu S; Luo H
    Gastroenterol Res Pract; 2019; 2019():9759138. PubMed ID: 31885549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting the Gut Microbiota to Relieve the Symptoms of Irritable Bowel Syndrome.
    Wollny T; Daniluk T; Piktel E; Wnorowska U; Bukłaha A; Głuszek K; Durnaś B; Bucki R
    Pathogens; 2021 Nov; 10(12):. PubMed ID: 34959500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-level inflammation, immunity, and brain-gut axis in IBS: unraveling the complex relationships.
    Yuan Y; Wang X; Huang S; Wang H; Shen G
    Gut Microbes; 2023 Dec; 15(2):2263209. PubMed ID: 37786296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gut Dysbiosis in Irritable Bowel Syndrome: A Narrative Review on Correlation with Disease Subtypes and Novel Therapeutic Implications.
    Napolitano M; Fasulo E; Ungaro F; Massimino L; Sinagra E; Danese S; Mandarino FV
    Microorganisms; 2023 Sep; 11(10):. PubMed ID: 37894027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.